BOTANIX PHARMACEUTICALS LTD

Botanix (BOT.AX) slumps 15%—a 52‑week low at AUD 0.01. Explore why the dermatology drugmaker’s price fell and compare it to peers like Zinctek and True North Copper.

Botanix (BOT.AX) rises 8.3% after modest Sofdra sales growth; learn how cost‑cutting and cash runway plans drive the next phase for the dermatology firm.

Botanix Pharma drops 7.7% as price slides to AUD 0.01 – market cap falls to AUD 32.8 m after 36.8% slump. Get the latest trading insights and 52‑week highs.